Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	105.29	94.42	45.99
Graham Fair Price	-47.80	5097.11	9763.80
PEG	-1483.78	-0.09	< 0.005
Price/Book	24.67	0.59	0.47
Price/Cash Flow	-74.46	14.24	-55.74
Prices/Earnings	499.43	7.18	1.20
Price/Sales	44.37	3.70	2.56
Price/FCF	-74.46	14.24	-55.74
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-4.88	0.50	0.53
Operating Margin	-92.67	< 0.005	0.11
ROA	-77.08	< 0.005	0.02
ROE	0.10	0.02	-79.20
ROIC	< 0.005	< 0.005	-88.81
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.02	-0.02	-4.88
Dividends QOQ	43.45	-0.72	-98.35
EBIT QOQ	0.34	-0.93	172.61
EPS QOQ	2.01	-0.76	-62.15
FCF QOQ	0.09	6.59	7369.64
Revenue QOQ	0.06	-0.01	-81.92
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	19.36	16.60	-14.26
Days Sales Outstanding (DSO)	142.25	161.84	13.77
Inventory Turnover	4.65	5.42	16.63
Debt/Capitalization	0.68	0.66	-3.71
Quick Ratio	0.79	0.68	-13.70
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	6537.14	7482.92	14.47
Cash	4625.19	4391.86	-5.04
Capex	-106.44	-72.01	32.35
Free Cash Flow	-55.68	311.10	458.71
Revenue	1210.88	1196.98	-1.15
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.90	0.82	-9.72
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	35.27	66.38	88.20
Naive Interpretation	Member

06 - Financial Health · Bad

Rating